Dominique Dubois
Clinical Instructor
Also affiliated: Cliniques Universitaires Saint-Luc (2004–2025); Université Libre de Bruxelles (2010–2021); Johnson & Johnson (United States) (2004–2010); Janssen (Belgium) (1998–2007); Centre Hospitalier Universitaire de Toulouse (2021); Sorbonne Université (2021–2022); Geneeskundige en Gezondheidsdienst (2002); DH Consultancy BVBA (Belgium) (2008–2010); Pfizer (Belgium) (1991); Millennium Engineering and Integration (United States) (2006); Janssen (United States) (2002); Hôpital Charles-Foix (2021–2022); IQ Solutions (2008); Université d'Angers (2001); International Pharmaceutical Federation (2015–2016); Paris School of Economics (2015); UCLouvain (2024)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dominique Dubois' research investigates health outcomes and predictive markers across diverse populations, with a recent focus on the impacts of societal events and biological factors on health. Dubois has published work examining the intrinsic capacity domain of vitality in older adults, exploring its measurement through nutritional status, handgrip strength, and aging biomarkers. Further studies have investigated associations between plasma markers like Growth Differentiation Factor 15 (GDF-15) and physical performance, cognitive functions, and neurofilament light chain levels in community-dwelling older adults.
In parallel, Dubois' work addresses the health implications of major public health events. This includes research on the association of the COVID-19 pandemic with Women, Infants, and Children (WIC) receipt among pregnant individuals and the impact of the 2022 infant formula shortage on self-reported rates of anxiety and depression. Additionally, Dubois has explored predictive markers for pathological complete response in HER2-positive breast carcinoma and the evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant breast carcinomas. Dubois' scholarship metrics include an h-index of 26, 4,417 total citations, and 99 total publications.
Metrics
- h-index: 27
- Publications: 99
- Citations: 4,472
Selected Publications
-
Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization (2025)
-
Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression (2024)
-
Racial/Ethnic Disparities in Pregnancy-Associated Death: The Critical Importance of Disaggregation by Cause of Death and Race/Ethnicity (2024)
-
P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023 (2024)
-
Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022 (2023)
Collaboration Network
Top Collaborators
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Racial/Ethnic Disparities in Pregnancy-Associated Death: The Critical Importance of Disaggregation by Cause of Death and Race/Ethnicity
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
Similar Researchers
Based on overlapping research topics